AmSurg receives average “buy” rating

Eleven analyst firms have given AmSurg stock an average rating of “buy,” according to a report from The Legacy.

Advertisement
Carrie Pallardy

AmSurg stock has an average 12-month price target of $67.45. The company’s stock has a 50-day moving average of $65 and a 200-day moving average of $58, according to the report.

More articles on transactions and valuation issues:
4 recent orthopedics-driven ASC plans & openings
Ellis Hospital is crowdfunding its new surgery center: 4 insights
Nobilis Healthcare receives $25M loan from GE Capital

20 criteria hospital leaders should use to evaluate telepsychiatry

Recommended Whitepaper

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • An academic system's ASC learning curve

    ASCs have taken center stage of many hospital and health systems’ growth and development strategies in recent years as they…

    By: Francesca Mathewes

  • Portland ASC to open in late 2026

    Germantown, Md.-based Capital Surgical Solutions plans to open a new ASC in Portland, Ore., in the fourth quarter of 2026,…

    By: Sophie Eydis

  • The threats ASCs don’t see coming — yet

    Rising volumes and strong demand have masked some of the biggest vulnerabilities facing ASCs.  Six ASC leaders joined Becker’s to…

    By: Patsy Newitt
Advertisement

Comments are closed.